Muller WJ - Search Results

1

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.

Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, Huang H, Kuo HP, Lee DF, Li LY, Lien HC, Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, Sahin AA, Muller WJ, Mills GB, Yu D, Hortobagyi GN, Hung MC. Yang JY, et al. Among authors: muller wj. Nat Cell Biol. 2008 Feb;10(2):138-48. doi: 10.1038/ncb1676. Epub 2008 Jan 20. Nat Cell Biol. 2008. PMID: 18204439 Free PMC article.

2

Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.

Cheng X, Xia W, Yang JY, Hsu JL, Lang JY, Chou CK, Du Y, Sun HL, Wyszomierski SL, Mills GB, Muller WJ, Yu D, Hung MC. Cheng X, et al. Among authors: muller wj. Cancer Res. 2010 Oct 1;70(19):7684-9. doi: 10.1158/0008-5472.CAN-09-3231. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841468 Free PMC article.

3

Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis.

Cheng X, Xia W, Yang JY, Hsu JL, Chou CK, Sun HL, Wyszomierski SL, Mills GB, Muller WJ, Yu D, Hung MC. Cheng X, et al. Among authors: muller wj. Biochem Biophys Res Commun. 2010 Dec 3;403(1):103-7. doi: 10.1016/j.bbrc.2010.10.126. Epub 2010 Oct 30. Biochem Biophys Res Commun. 2010. PMID: 21040707 Free PMC article.

4

14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition.

Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, Shi B, Ling C, Zhou X, Chen T, Chiao PJ, Feng X, Seewaldt VL, Muller WJ, Sahin A, Hung MC, Yu D. Lu J, et al. Among authors: muller wj. Cancer Cell. 2009 Sep 8;16(3):195-207. doi: 10.1016/j.ccr.2009.08.010. Cancer Cell. 2009. PMID: 19732720 Free PMC article.

5

Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Mills GB. Liu S, et al. Cancer Cell. 2009 Jun 2;15(6):539-50. doi: 10.1016/j.ccr.2009.03.027. Cancer Cell. 2009. PMID: 19477432 Free PMC article.

6

Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer.

Wang Q, Li SH, Wang H, Xiao Y, Sahin O, Brady SW, Li P, Ge H, Jaffee EM, Muller WJ, Hortobagyi GN, Yu D. Wang Q, et al. Among authors: muller wj. Cancer Res. 2012 Sep 1;72(17):4417-28. doi: 10.1158/0008-5472.CAN-12-1339-T. Epub 2012 Jul 6. Cancer Res. 2012. PMID: 22773664 Free PMC article.

7

Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors.

Sahin O, Wang Q, Brady SW, Ellis K, Wang H, Chang CC, Zhang Q, Priya P, Zhu R, Wong ST, Landis MD, Muller WJ, Esteva FJ, Chang J, Yu D. Sahin O, et al. Among authors: muller wj. Cell Res. 2014 May;24(5):542-59. doi: 10.1038/cr.2014.37. Epub 2014 Mar 28. Cell Res. 2014. PMID: 24675532 Free PMC article.

8

14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation.

Rehman SK, Li SH, Wyszomierski SL, Wang Q, Li P, Sahin O, Xiao Y, Zhang S, Xiong Y, Yang J, Wang H, Guo H, Zhang JD, Medina D, Muller WJ, Yu D. Rehman SK, et al. Among authors: muller wj. Cancer Res. 2014 Jan 1;74(1):363-373. doi: 10.1158/0008-5472.CAN-13-2016. Epub 2013 Nov 6. Cancer Res. 2014. PMID: 24197133 Free PMC article.

9

Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.

Boulay PL, Mitchell L, Turpin J, Huot-Marchand JÉ, Lavoie C, Sanguin-Gendreau V, Jones L, Mitra S, Livingstone JM, Campbell S, Hallett M, Mills GB, Park M, Chodosh L, Strathdee D, Norman JC, Muller WJ. Boulay PL, et al. Among authors: muller wj. Cancer Res. 2016 May 1;76(9):2662-74. doi: 10.1158/0008-5472.CAN-15-2782. Epub 2016 Mar 1. Cancer Res. 2016. PMID: 26933086 Free PMC article.

10

Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.

Dillon RL, Marcotte R, Hennessy BT, Woodgett JR, Mills GB, Muller WJ. Dillon RL, et al. Among authors: muller wj. Cancer Res. 2009 Jun 15;69(12):5057-64. doi: 10.1158/0008-5472.CAN-08-4287. Epub 2009 Jun 2. Cancer Res. 2009. PMID: 19491266 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page